Mon.Mar 24, 2025

article thumbnail

STAT+: 23andMe’s bankruptcy is the worst thing that could happen to just about everyone involved

STAT

How did 23andMe go bankrupt? The same way bankruptcy was described by Ernest Hemingway in 1926: “Two ways: Gradually, and then suddenly.” Since its founding in 2006, the company, which aimed to give consumers access to their genetic information, faced what seemed like one killing blow after another: questions of whether its business was ethical, the Food and Drug Administration blocking the sale of its tests, and, last year, a cyberattack in which hackers gained access to the recor

361
361
article thumbnail

Biotechs emerging from stealth take aim at pharma’s prime targets

PharmaVoice

The companies are striving to bring fresh innovations to cancer care, pain management and the weight loss space.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: 23andMe files for bankruptcy as CEO Anne Wojcicki resigns

STAT

23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne Wojcicki will depart, after she repeatedly tried and failed to take the storied but financially troubled DNA-testing startup private.  The company will now try to sell itself through a court-supervised sale. It closed Friday valued at a hair under $50 million, a calamitous fall from 2021, when it went public and soared to a nearly $6 billion market cap.

348
348
article thumbnail

How to stay updated on Marketing Pharma News

Pharma Marketing Network

In a world where innovation, regulation, and consumer behavior shift rapidly, keeping up with pharma news is not just helpfulits essential. For pharma marketing executives and their teams, staying current helps maintain competitive advantage, ensures compliance, and unlocks opportunities for smarter, faster campaign decisions. With new drug approvals, branded marketing trends, and policy updates emerging weekly, how can pharma marketers stay informed without becoming overwhelmed?

52
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Opinion: Five years ago, early career researchers needed help to survive the pandemic. Now they need it again 

STAT

Five years ago, the Covid-19 pandemic swept through the world, resulting in massive disruptions, including to biomedical researchers. As National Institutes of Health-funded physician-scientists, we collectively experienced the pitfalls of lab closures, pauses in clinical trial recruitment due to staffing issues and social distancing policies affecting in-person accrual, and redeployment away from research work to the frontlines to support clinical care.

315
315

More Trending

article thumbnail

Lawmakers are pushing the HALT Fentanyl Act as the solution to the overdose crisis. Experts warn it will fall short

STAT

WASHINGTON — Five days after discovering their 16-year-old son Daniel Puerta unresponsive in bed, Jaime Puerta and his wife decided to discontinue life support as they stood beside him in the Los Angeles Children’s Hospital. Puerta kissed his son’s nose one last time. Daniel, who had no history of drug use, is one of countless stories tragically connected to the nation’s opioid crisis.

Hospitals 284
article thumbnail

Protect Temperature-Sensitive Pharmaceuticals Without the Unnecessary Plastic Waste

Pharmaceutical Commerce

Peter Wells, CEO of TemperPack, discusses the life sciences industry's shift toward sustainable packaging, particularly in cold chain logistics, to replace outdated petroleum-based materials like expanded polystyrene (EPS). His insights cover the growing importance of sustainability as a business driver, emphasizing efficiency, waste reduction, regulatory pressures, and emerging innovations in biodegradable and recyclable packaging solutions.

article thumbnail

Opinion: STAT+: Philanthropy can help create a healthier biotech ecosystem

STAT

Small, early-stage biotech startups are the heart of drug innovation in the U.S. Growing anti-competitive challenges threaten their work, but philanthropy may offer an avenue forward. At the center of these challenges is the U.S. patent system and how it incentivizes anti-competitive behavior among the most powerful players. The argument is that patents — meant to spur innovation — are being gamed by drug manufacturers to extend monopoly profits and exclusivity, stifling competitio

256
256
article thumbnail

Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste

Pharmaceutical Commerce

Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: Pharmalittle: We’re reading about 23andMe bankruptcy filing, the case against ‘global freeloading,’ and more

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and messages has returned. But what can you do? There is no pause button to stop the world from spinning. To cope, we are quaffing cups of stimulation. Our choice today is peppermint.

194
194
article thumbnail

23andMe files for bankruptcy protection

pharmaphorum

DNA testing specialist 23andMe has filed for bankruptcy and co-founder and chief executive Anne Wojcicki has stepped down.

107
107
article thumbnail

The closest hospital vs. the one people actually deliver at

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Good morning! I’ve got a meaty issue for you here to start the week. Thanks so much for reading.

Hospitals 239
article thumbnail

Accelerate oncology drug development: A data-driven approach to clinical decisions

BioPharma Dive

Speed vs. success in oncology trials: Discover data-driven strategies to accelerate drug development.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Informa Connect’s Life Sciences Pricing & Contracting USA

Drug Channels

Informa Connects Life Sciences Pricing & Contracting USA May 19-21, 2025 | Philadelphia, PA Drug Channels readers save 10% with code 25DRCH10* Pricing & Contracting USA arrives at an important moment for our industry. As you work to navigate the evolving healthcare landscape, this annual event brings together 60+ expert speakers from 70+ companies to lead the critical discussions that will drive comprehensive market strategy, uniting Medicaid, Policy, Pricing, Contracting & Reporting

article thumbnail

AstraZeneca to invest $2.5bn in R&D centre in China

Pharmaceutical Technology

AstraZeneca has announced a $2.5bn investment to establish the companys sixth worldwide strategic R&D centre in China.

87
article thumbnail

Novo Nordisk looks east for another obesity therapy

pharmaphorum

Novo Nordisk has moved to shore up its obesity pipeline with a $2bn licensing deal for a triple agonist developed by China's United Biotechnology

85
article thumbnail

WHO adds first maternal RSV vaccine to prequalification list

Pharma Times

Pfizers Abrysvo is designed to prevent RSV-associated disease in infants

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Novo adds to obesity drug pipeline via $200M deal with China-based biotech

BioPharma Dive

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

75
article thumbnail

New Report Finds More Abuse of 340B Program by Hospitals and Drug Middlemen

PhRMA

A new report by the Wall Street Journal reveals abuse of the 340B hospital markup program is getting worse as hospitals and middlemen find new ways to profit off the program.

article thumbnail

MIT team develops 'years-long' drug delivery tech

pharmaphorum

Researchers in the US have devised a new depot system that could provide months or even years of delivery from a single subcutaneous injection.

66
article thumbnail

Verve gets FDA green light to expand base editing trial into US

BioPharma Dive

The company expects next quarter to read out initial data from its Heart-2 trial, which is testing a one-time treatment for people with genetically elevated cholesterol.

64
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Phase 3 readout puts Opthea at risk of insolvency

pharmaphorum

After its lead wet AMD drug failed a phase 3 trial, Opthea may have to make massive repayments to investors that would threaten its viability

66
article thumbnail

Tempero Bio gets $70M to advance substance abuse treatment

BioPharma Dive

The Series B round will help the Aditum Bio-backed startup fund two mid-stage clinical trials in people with alcohol and cocaine use disorders.

64
article thumbnail

Why AI and ethics are needed for the future of pharma investment

pharmaphorum

Explore the importance of incorporating AI and ethics in pharmaceutical investment for the future. Learn about the impact and benefits of these technologies in the industry.

64
article thumbnail

PAP 2025: The Unfinished Work of Healthcare Reform

Pharmaceutical Commerce

Jonathan James, CEO, Hope Charities, discusses how, despite policy advancements, millions of people still face barriers to healthcare access.

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.